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Background: The deciphering of cellular networks to determine susceptibility to infection by HIV or the related
simian immunodeficiency virus (SIV) is a major challenge in infection biology.
Results: Here, we have compared gene expression profiles of a human CD4+ T cell line at 24 h after infection
with a cell line of the same origin permanently releasing SIVmac. A new knowledge-based-network approach
(Inter-Chain-Finder, ICF) has been used to identify sub-networks associated with cell survival of a chronically
SIV-infected T cell line. Notably, the method can identify not only differentially expressed key hub genes but also
non-differentially expressed, critical, ‘hidden’ regulators. Six out of the 13 predicted major hidden key regulators
were among the landscape of proteins known to interact with HIV. Several sub-networks were dysregulated
upon chronic infection with SIV. Most prominently, factors reported to be engaged in early stages of acute viral
infection were affected, e.g. entry, integration and provirus transcription and other cellular responses such as
apoptosis and proliferation were modulated. For experimental validation of the gene expression analyses and
computational predictions, individual pathways/sub-networks and significantly altered key regulators were
investigated further. We showed that the expression of caveolin-1 (Cav-1), the top hub in the affected protein-protein
interaction network, was significantly upregulated in chronically SIV-infected CD4+ T cells. Cav-1 is the main
determinant of caveolae and a central component of several signal transduction pathways. Furthermore, CD4
downregulation and modulation of the expression of alternate and co-receptors as well as pathways associated
with viral integration into the genome were also observed in these cells. Putatively, these modifications interfere
with re-infection and the early replication cycle and inhibit cell death provoked by syncytia formation and
bystander apoptosis.
Conclusions: Thus, by using the novel approach for network analysis, ICF, we predict that in the T cell line
chronically infected with SIV, cellular processes that are known to be crucial for early phases of HIV/SIV
replication are altered and cellular responses that result in cell death are modulated. These modifications
presumably contribute to cell survival despite chronic infection.
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Table 1 Comparison of viral load in lytic versus chronic
infection of CD4+ T cell line C8166
SIVmac251/C8166 Lytic infection Chronic infection
Percentage of infected cells1 25% 100%
Copy number2 0.3 2-3
Viruses in supernatant3 3 300
Provirus integration4 18% n.d.5
1As determined by indirect immune peroxidase assay.
2Copies per SIV DNA as determined by proviral specific PCR.
3Particles per cell at one day after infection or medium exchange by means of
PCR analysis.
4Halo-FISH analysis, integration into transcriptionally active matrix regions.
5 n.d. not detectable by Halo-FISH analysis.
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SIV (simian immunodeficiency virus)-infected macaques
represent the most accepted model for HIV infection.
Therefore, the investigation of SIV/host interactions
gives valuable insights into cellular strategies against
viral invasions and illuminates viral strategies to coun-
teract cellular defense [1]. Three different types of HIV/
SIV infections can be distinguished. Acute infection is
characterized by virus replication and subsequent lysis of
CD4+ T cells. In a latent infection, virus production is
extremely low or repressed, whereas the virus genome is
still detectable and viruses reside in a poorly defined cel-
lular reservoir. This type of infection can be observed in
elite controllers. A pattern of infection mainly observed
in vitro refers to a chronic infection that is characterized
by a permanent virus production in cells that are not
harmed by virus replication. Although a considerable
number of factors have been identified as interfering
with the HIV replication cycle in T cells and although
factors that give rise to the survival of HIV-1-infected
macrophages have been reported, the determinants of
the resistance of certain patients to HIV-1 infection are
not fully understood [2-8]. Thus, the permanently SIV/
HIV CD4+ producing T cell lines are valuable models for
studying survival mechanisms in cells that represent
primary targets of HIV-1/SIV infection. The monitor-
ing of changes in gene expression on a genome scale is
a powerful tool for examining transcriptional programs
involved in virus pathogenesis. To date, several investi-
gations using gene expression profiling for understand-
ing HIV/SIV host interaction have been reported
[1,9-15]. In order to obtain greater insights into the
genetic networks, main regulators and mechanisms as-
sociated with cell survival in a chronic infection, we
have compared the cellular responses to acute and
chronic types of SIV-infection of a human CD4+ T cell
line. A human T cell line was chosen for scientific reasons,
because little is known of the gene expression pattern in
SIV-infected human T cells, and for technical reasons, be-
cause of the unique availability of this specific cell line.
Furthermore, the current version of the computational ap-
proach (Inter-Chain-Finder, ICF) is based on molecular
interactions in human cells.
To identify molecules at a systemic level that might
govern cell survival despite chronic SIV infection of the
human CD4+ T cell line, we have applied a conventional
pathway analysis of cDNA microarray data. Furthermore,
we have implemented a new strategy for knowledge-based
network analysis able to localize significantly affected sub-
networks and non-differentially transcribed (‘hidden’) key
transcription factors. Identification of the latter is very
challenging but essential since many regulators are only
post-transcriptionally activated/inhibited and such alter-
ations are not recorded by standard microarray analysis.Following the network-based analysis, selected targets
have been subsequently studied by experimental inves-
tigations. Our results indicate that early steps in viral
multiplication (entry, integration, transcription) are
preferentially affected in chronically SIV-infected T
cells; this together with other factors might contribute
to the phenotypes observed.
Results and discussion
Characterization of a lytically SIVmac251/H32 -infected human
CD4+ T cell line and a model CD4+ T cell line permanently
releasing SIV with respect to virus count and proviral state
To identify a survival network in the chronic type of
infection, we compared the global gene expression of
the permanently SIV-releasing CD4+ human T cell line
C8166 (C8166-P) with the gene expression pattern of
acutely infected and mock-infected cells [16]. An early
time-point (24 h) after acute infection was chosen to
study the appearance of cellular responses, extensive
replication leading to cell damage not having yet
occurred.
To characterize the individual courses of SIV infection,
we compared a combination of various parameters, such
as virus copy numbers, percentage of infected cells, the
virus particle numbers released and the chromosomal
status of the provirus. Determination of viral DNA copy
numbers by polymerase chain reaction (PCR) revealed
that 0.3 copies of SIV DNA per cell were found on aver-
age in the acute SIV infection, whereas 2–3 copies of the
SIV DNA were present in permanently SIV-releasing
T cells (Table 1). As infected cells can harbour up to 8
proviruses, and the cell line is in permanent contact
with infectious virus, it is speculated that the perman-
ently SIV-releasing cell line resists some degree of re-
infection [17]. An indirect immunoperoxidase assay
was used to determine the percentage of infected cells
in acute and chronic infection. In acute infection, about
25% of cells were positive for SIV staining, whereas all
of the chronically infected T cells expressed viral pro-
teins. Furthermore, the numbers of viruses released
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PCR analysis. The population of acutely infected cells is
heterogeneous. Thus, gene expression analysis may have
been affected through a change of the transcriptional
profile by contact of CD4 or CCR5 with Env on virions
on infected and uninfected cells [18]. To account for
that fact and to achieve a kind of standardization we in-
troduced a ‘multiplicity of contact’ concept into our ex-
perimental settings. For that purpose, we determined
viral particle numbers (see M&M Infection and RNA
isolation for details) and took care, that the number of con-
tacts with virions and cells was similar for both cell lines.
Infection experiments also revealed a low number of
viral particles (3 per cell on average) in the supernatant
of acutely infected T cells after day 1 which is consistent
with the notion that a full SIV-replication round is not
completed at that time. On the contrary, chronically
SIV-infected T cells released 300 SIV particles per cell
on average. Obviously, the released viruses do not harm
neighbouring T cells, albeit they are highly infectious
and replicate to a similar extent as SIVmac239 and SIV-
mac251 in naïve C8166 cells and monkey lymphocytes
(Additional file 1: Figure S1). Last, the chromosomal
status of provirus in acute infection was determined by
Halo-FISH (fluorescence in situ hybridization) analysis
(Figure 1). In addition to copy number determination,
this method differentiates between integration into loop
and matrix-attached regions of the chromosome. By
using the probe pGX10-SIV-GE, which contains Gag
and Env coding regions of SIVmac251, Halo-FISH
showed that about 18% of the acutely infected cells har-
boured provirus that was integrated predominantly into
the matrix regions (transcriptionally active domains), but
not into loop-regions (transcriptionally silent domains)
(Figure 1). Thus, the different techniques for estimating the
percentage of acutely infected cells or viral DNA copy
number were in relative good agreement. Interestingly, des-
pite various modifications in salt extraction, the Halo-Fish
method failed to give results regarding the chromosomal
integration status of SIV in chronically infected T cells.
The reason for this is not clear but indicates that the inner
milieu of these cells has changed dramatically.
Principle, features and generality of the network strategy
An essential limitation of microarray-based techniques is
that post-transcriptional modifications that regulate
cellular processes by activation or inhibition cannot be
detected at all. To partially compensate this lack, we
applied a novel strategy termed Inter-Chain-Finder (ICF)
which is able to identify upstream regulators whose tran-
scriptional change and/or predicted change of transcrip-
tional regulatory activity can drive differential expression
of target genes. The ICF can uncover significantly affected
interactive molecular chains (IMCs) that might affect theactivities of non-differentially-expressed (NDiff) transcrip-
tion factors. A representation of the new strategy is depic-
ted in Figure 2 (for details, see Materials and methods).
First, an integrated human molecular network is construc-
ted by including information on transcriptional regulations,
signalling transduction interactions (or protein-protein in-
teractions) and metabolic reactions. Then, the expression
data are used to reveal changes in the integrated network
at various molecular levels. The ICF subsequently system-
ically traces and identifies all the possibly significantly af-
fected IMCs that might modulate the activities of NDiff
regulators (Figure 2 and Additional file 2: Figure S3). The
essential hypothesis behind ICF is that if both upstream
and downstream factors of a given non-differentially tran-
scribed regulator are significantly affected, the activity of
the given NDiff regulator is also most likely affected (for
details, see Materials and methods, the scheme in Figure 2
and the example in Additional file 3: Figure S4).
In contrast to the other available approaches which
can mainly identify differentially expressed (Diff ) genes
or Diff networks or pathways, the ICF not only un-
covers the signal transduction, metabolic and regula-
tory sub-networks disturbed at the transcriptional level
upon the conditional changes, but also reveals NDiff
‘hidden’ regulators and explains how the Diff genes are
regulated. This is achieved by tracing back affected sig-
naling transduction chains. The capability of being able
to infer and interpret NDiff potential ‘hidden’ key regula-
tors has partially compensated the essential limitation of
microarray-based techniques in which post-transcriptional
modifications cannot be detected at all. Furthermore, we
identify and rank affected sub-networks based on calcula-
tion of the number of affected interactions rather than the
number of Diff genes and with no requirement of the differ-
ential expression for each individual gene in the affected in-
teractions (see Materials and methods). Since all biological
processes are exerted through molecular interactions rather
than independent genes/proteins, we believe that the calcu-
lation based on interactions is more biologically relevant
than that based on individual genes by other approaches.
The revelation of such sub-networks and potential
‘hidden’ key regulators is the original aspect of this work
compared with other methods of network-based ana-
lysis, which are, for example, applied for the analysis of
systemic inflammation in humans [19], specific inflam-
matory diseases [20,21] or lung cancer [22]. Although
the method used for lung cancer analysis [22] previously
noted “hidden” regulators, the strategy did not trace sig-
nificantly affected IMCs in order to identify those regu-
lators. Finally, ICF can be generally used to uncover
molecular responsive networks of various organisms
provided a corresponding integrated molecular network
of the respective organism and sufficient knowledge of
its molecular interactions are available.
SIV probeDAPIMerged
Figure 1 Halo-FISH analysis of acutely SIV-infected C8166 T cells. Integration of SIV into the genomic DNA of the C8166 T cell line. Three
acutely SIV-infected cells were shown in three different rows. Halo-FISH analyses of cells 1 d after acute infection was performed by using a SIV
gag-env DNA probe. Nuclei were visualized by DAPI staining. Single integration events of SIV proviral DNA (SIV probe, white spots; Merged with
DAPI staining, red spots) into the nuclear matrix at regions of high transcriptional activity (blue sphere) are clearly visible. No integration into the
associated HALO (regions of low transcriptional activity surrounding the nuclear matrix) was observed.
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activation of multiple survival sub-networks that interfere
with viral replication cycle
To investigate the way that the type of infection affects
gene expression at the transcriptional level, genome-
wide transcription was measured in chronically,
acutely infected and non-infected control CD4+ T cells
(Affymetrix HG_U133A microarray, measured by Dr.
Geffers, Microarray platform, HZI). Two independent
experiments were done 6 months apart and cells from
different passages were used to minimize problems related
to the genetic drifting of the cell lines. Data from chronic-
ally and acutely infected cells and mock-infection were
compared after threshold levels had been defined by stan-
dard methods (see Materials and methods). Upon chronic
infection, 190 genes were upregulated and 139 down-
regulated compared with control cells (Additional file 4).
Acute infection resulted in the upregulation of only 22
genes and the downregulation of 9 genes.Affected biochemical and regulatory pathways were iden-
tified initially by visual inspection, the GO-viewer software
(Guido Diettrich, HZI) and the DAVID annotation program
[23] with emphasis on Diff genes and gene families. Sub-
networks and several presumed key regulators, which are,
however, not necessarily differentially expressed, were iden-
tified by the new network-based method ICF (for details of
the strategy, see Materials and methods and the scheme in
Figure 2). A selection of affected sub-networks is depicted
in Figures 3 and 4 and in Additional file 5: Figure S2.
In the chronically SIV-infected cells, genes controlling
cell cycle and apoptosis were affected similar to results
from chronically infected HIV T cell lines. Most strikingly,
mainly sub-networks and gene families were affected in
the chronically SIV-infected T cell line that are involved in
early steps of an acute infection in the viral replication
cycle, rather than in the late phase, such as viral entry,
integration and early responses to viral infection. In the
following, a selection of several sub-networks linked to
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Figure 2 Strategy and principle of Inter-Chain-Finder (ICF). A. Strategy of deciphering the response of model organisms to conditional
changes on the genome scale by an integrative approach based on an integrated network. First, an integrated network is constructed.
Gene-profiling data are subsequently used to identify affected interactions in the integrated network at the molecular levels. The ICF then traces
back all affected interactive molecular chains (IMCs) and identifies non-differentially (NDiff) and differentially expressed (Diff) key regulators. Finally,
regulators and the affected sub-networks are displayed by Cytoscape. The steps in bold are the core steps. The key steps are explained in detail
in the Materials and methods. B. Demonstration of the tracing approach for possible, significantly affected IMCs mapping regulators, their upstream
effectors and downstream targets. Black arrow represents the direction of IMCs in the available signal network; red dashed arrow represents the
direction of chain tracing. R: Regulators (white, NDiff, green/red, Diff); D: Diff genes, red: upregulated, green: downregulated; N: NDiff genes, white.
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ation of selected affected genes, see Figure 5).
Loss of CD4 gene expression and putative impairment
of alternate routes of virus attachment and entry
Downregulation of CD4
SIV and HIV-1 entry are multi-step processes and the
mechanism of entry is cell-dependent. CD4 representsthe most important cellular receptor for HIV-1 and
SIV and is involved in syncytium formation in infected
cells. The microarray experiments, real-time RT-PCR
(reverse transcription with PCR) and FACS (fluorescence-
activated cell sorting) analysis revealed that CD4 mRNA
levels and cell surface expression were significantly reduced
in chronically SIV-infected Tcells (Figures 5, 6 and Table 2).
On average, the real-time RT-PCR results showed a 14- fold
SV2B
STAT6
JAK1
PIAS1
LAMA3
SDC2CD44
COL11A2
LAMA5
MAPK13MAPK12
APC
MRCL3
PHKA2
ROCK1
CALM1
RPS6KA3
DDIT4
RPS6KA1
CREBBP
EP300
CALM3
MYL5
CAMK2B
PHKB
CALM2
RHEB
AKT3
CAMK2G
TSC2
MRLC2
AKT1
PPP1CB
GNAI2
SOCS5
GNA11
GNA13
GNRHR
GNAS
GNA15
NFYC
CCND2
NFYB
CREB1
CIITA
GNAI3
RFX5
GRM1
RFXANK
LEF1
TCF7
TCF7L2
GSK3B
CTBP2
MAPT
MAPK3
DUSP1
MAPK14
DUSP8
MAPK1
DUSP5
RPS6KA2
MAPK9
DUSP7
PTPRF
INSR
SHC1 APC2
TBL1XR1
CTNNB1
SOS2
CACNA1A
RRAS2
RASGRP1
CACNB3
SOS1
KRAS
PLCG1
NRAS
PFN1
CFL1
ARPC1AARPC1B
ARPC4
ARPC5
ACTA2
TNFRSF14
PSME2
PSME3
IFNGR1
FYN
PDGFRL
CD247
SOCS2
SOCS3
IL15RA
TYK2
LILRB3
IRF9
PTPN6
SMAD4
SMAD1 BACE2
APP
CCL22
IFNGR2
PSME1
LTA
TNFRSF1B
CCR4
CCL17
IFNA16
TRAF2
RAC1
RAC2
IQGAP1
ACTG1
CDC42
ACTB
TP53
CHEK1
MAP3K1
MAP4K4
CHEK2
ARPC2
ARPC3
ROBO1
SLIT2
ATR
ARPC5L
MAP3K4
GADD45B
MAP2K4
PPM1A
PCNAMAP2K3
PDPK1
INPP5D
PRKCI
PAK2NCK2
CEBPA
LCP2
PTK2
RUNX1
COL6A1
COL5A3
GRB2
ERBB4
STAT5A
NOS1
CAV1
ITGB1
Figure 3 Main parts of signal transduction network significantly perturbed in chronically infected SIV C8166 CD4+ T cells. The different
colours of interactions correspond to different pathways as annotated by KEGG database (for details see the integrated database). The black
arrow represents activation (detailed relationship of interactions can be obtained in the database from authors on request); the black circle
represents inhibition; no edge end represents the undirected relationship PPI of the two proteins; the dashed line represents an indirect
relationship. Red color, significantly increased (see Materials and methods); green, significantly decreased; white, NDiff.
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infected CD4+ T cell line compared with mock-infected
cells (Table 2). The CD4 protein was only barely detectable
by FACS analysis in the permanently SIV-producing C8166
cells (Figure 6). Thus, in addition to the known mecha-
nisms of CD4 protein reduction by Env, Vpu and Nef
[24-28], CD4 expression appeared to be further repressed
in the permanently SIV-producing cell at the transcriptional
level. This is interesting, as transcriptional silencing might
serve for complete CD4 removal from the surface.
On the contrary, CCR5, the co-receptor used by SIV,
was hardly detectable in acute infection but was consider-
ably increased in chronic infection (Table 2). Chemokine
mRNAs of CCL3 (Table 2) or CCL5 (not shown) seem not
to be affected.Thus, CD4 loss should result in reduced infection,
syncytium formation, and Env-mediated apoptosis of
chronically infected cells considerably contributing to their
survival. In support of our assumption, down-modulation
of plasma membrane CD4 has previously been shown to
result in resistance to superinfection mediated by SIV Nef
protein and linked to the interference with re-infection in
chronically HIV-1 infected T cells [29-31]. Reduction of
CD4 cell surface expression has also been reported to result
in particles with fewer CD4 and more Env molecules,
which probably eases their release [6,7].
Impairment of alternate routes of infection
Infection by HIV/SIV is known to be facilitated by al-
ternate receptors or alternate routes, if the primary
Figure 4 Parts of the protein-protein network of CD4+ T cells significantly perturbed only during the chronic infection of SIV.
A zoom-in of the protein-protein network depicted in Additional file 5: Figure S2 is shown. Red colour, significantly increased; green, significantly
decreased; white, non-differentially expressed. Note the binding partners of Cav-1 and the linkages of Cav-1 to several other sub-networks, e.g.
insulin module (IGF2, IGFBP3) and p53 (TP53) subnetworks.
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In many cases, the HIV-interacting counterparts are lectins,
which are glycoproteins that interact with the highly glyco-
sylated lentiviral envelopes.
Strikingly, the glycosylation potential of permanently
SIV-releasing T cells might be altered, as the gene ex-
pression of several modifying glycosyltransferases was
decreased. For example, the gene expression of fuco-
syltransferase IV and VII (FUT4, FUT7), which add fu-
cose to glycans at the α-1,3 position, was diminished as
determined in microarray and real-time PCR experiments
(Figure 5A, Table 2). Branched fucose oligosaccharidesplay a role in attachment to the high mannose receptor
DC-SIGN [37,38]. DC-SIGN, a C-type lectin abundant in
dendritic cells, acts as an HIV receptor by binding Env in
a glycosylation-dependent manner [39,40]. Moreover, the
expression of a GlcNac-0-6 sulfotransferase (CHST7) was
increased in chronically SIV infected cells (data not shown)
and this might have an effect on HIV-binding to cells as the
type and amount of sulfation of Env carbohydrate residues
have been shown to affect Env affinity to DC-SIGN, CCR5
or syndecans [37,38,41]. Furthermore, sialyltransferase 9
(SIAT9, also termed ST3Gal5a) expression was consider-
ably upregulated in the chronically SIV-infected T cells
A
B
Figure 5 Cellular responses in chronically SIV-infected T cells and reported involvement in stages in acute SIV/HIV-1 infection of
susceptible cell types: putative contributions to cell survival. The perturbation of cellular processes known to be important for the early viral
replication cycle (A) and activity of cell growth genes (B) is predicted to confer survival of chronically SIV-infected T cells. Affected genes are listed
from microarrays of SIV-resistant T cells and are associated with their reported roles in the viral replication cycle. Alterations in mRNA levels were not
observed in acutely infected cells at 24 h after infection. Abbreviations and symbols: * or # inferred by the ICF. Differentially (green circle or red circle)
and non-differentially (○) expressed genes, suggested activity and regulator status. Cellular response 2- to 5-fold decrease (green circle) or increase
(red circle); more than 5-fold decrease (two green circles) or increase (two red circles); (○) no significant change in mRNA level.
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GM3, a glycosphingolipid. Interestingly, GM3 has been
identified as an attachment factor for HIV-1, thereby facili-
tating HIV infection under physiological conditions, but
clearly inhibiting HIV infection upon overexpression [42].
Finally, we have found that syndecan 4 (SDC4) expression
tended to downregulation in chronically SIV-infected T
cells, suggesting that another bypass in infection might be
compromised. Syndecans, including syndecan 4, have been
demonstrated to be able to function as cis and trans HIV
receptors via the binding of HIV-1 gp120 to the heparan
sulfate chains of syndecan. Syndecans can promote HIV in-
fection in the absence of CD4 in macrophage and epithelial
cells. Thus, syndecans perform multiple roles as they cap-
ture, protect and transmit HIV to T cells [34,43].
Taken together, the results suggest that a modified
carbohydrate moiety in chronically infected T cells might
impair the attachment of SIV and also restrict alternate
routes of infection.
Significantly affected sub-networks involving caveolin-1
By investigating the affected protein-protein network,
we could identify the most significantly affected hubs.Additional file 6: Table S1 lists the top 20 upregulated
hubs (for the downregulated hubs, see Additional file 7:
Table S2). Our results showed that caveolin-1 (Cav-1) was
the first among the upregulated hubs (Figures 3, 4, and 5A
and B, Additional file 5: Figure S2). In our protein-protein
network, we found that 40 out of 81 known interactions
with Cav-1 were affected (cumulative binomial distribu-
tion, P-value is 0, Additional file 6: Table S1). As hubs in
the identified network might represent essential genes for
physiological or pathological processes [44-47], we consid-
ered Cav-1 as a key responsive gene. Microarray results
showed that Cav-1 RNA abundance was increased nearly
5-fold in chronically infected T cells. In addition, real-time
RT-PCR experiments demonstrated a 4-fold increase in
Cav-1 RNA level in SIV C8166 producing cells, whereas
the RNA level in acutely infected cells remained un-
changed (Table 2). Cav-1 protein expression was verified
in Western blots, in which the 22 kD protein was present
in chronically infected cells, but absent in the mock-
infected control (Figure 7). Thus, caveolin-1 expression
was induced in C8166 T cells chronically infected with SIV.
This is surprising, as Cav-1 is usually not expressed in
CD4+ T cell lines [48,49] and in resting and TCR-stimulated
Figure 6 CD4 surface expression in SIV-infected C8166 T cell
line determined by FACS analysis. CD4 surface expression on
uninfected (upper panel) and chronically infected (lower panel)
C-8166 cells as determined by flow cytometry. Blue lines depict
unstained control samples, red lines staining with an antibody
directed against CD4. Chronically infected cells display a slightly
higher auto-fluorescence and only a little CD4 expression compared
with uninfected cells.
Table 2 Real-time RT-PCR analysis of suspected key com-
ponents of the response to chronic SIV-infection
Gene Microarray RT-PCR
Acute1 Chronic1 Acute Chronic
Cav-1 1 4.82 1 4
CCL3 1 0.7 1 1
CCR5 1 1.4 n. d.2 >20
CD3Z 1 11.68 1 13
CD4 1 0.12 1.8 0.06
CD44 1 2.69 1.35 11
Fut-7 1 0.12 1.25 0.095
IL2-RA 1 0.59 1.25 0.29
1RNA from acutely or chronically SIVmac251-infected or mock-infected C8166 T
cells was used for the experiments. Values represent the ratios between signals
(average fold change) derived from infected and mock-infected cells and are
derived from at least 2 independent experiments.
2not detectable.
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represents the main component of caveolae and functions
as a mediator in various signalling processes by establish-
ing signalling-competent complexes by binding through a
scaffolding domain within Cav-1. More recent data sug-
gest that Cav-1 also orchestrates T-cell receptor function
in CD8+ T cells [50]. Furthermore, Cav-1 is involved in
intracellular molecule transport and positioning, e.g. it
acts as a transporter of intracellular cholesterol and also
positions newly synthesized Gag of the γ–retrovirusmouse leukemia virus (MLV) at lipid rafts [51,52]. Not-
ably, various interactions with matrix proteins of other
viral families have been reported, e.g. influenza virus and
parainfluenza virus 5 [53-55]. Caveolae have been impli-
cated in SV40 virus entry; however, caveolae participation
in the HIV/SIV entry process has not been reported.
Thus, Cav-1 contributes in a structural manner and
binds proteins for positioning in or at lipid rafts, transport
through the cytoplasm or interference with the function
of viral proteins. Furthermore, Cav-1 might orchestrate
cellular signalling events leading to cell survival in SIV
infection. Various sub-networks, such as the activation
of the insulin subnetwork represented by upregulation
of (PTPRF, INSR, IGF2) (Figure 4) and downregulation
of the inhibitor PPP1CB (protein phosphatase 1, cata-
lytic subunit, beta isoform) of phosphorylase kinase
alpha 1 (PHKA1) (Figure 3, Additional file 2: Figure S3
and Additional file 5: Figure S2), in which caveolin-1 is
involved [56] have been identified by our network
strategy ICF. The identification of the insulin module
is corroborated by the recent finding, obtained by an
RNAi screen, showing that Akt (protein kinase B), another
player in the insulin-regulated network, is involved in HIV-
1 replication in infected cells, linking viral replication to
cellular survival and energy metabolism. Another ex-
ample comprises the known EGFR binding of Cav-1
and upregulation of CD44 (hyaluronic acid receptor)
(Figures 3 and 4, Table 2). CD44 is linked to T cell devel-
opment and signal transduction leading to proliferation.
Furthermore, integrin-fyn interaction, the insulin pathway
activation (PTPRF, INSR) (Figure 4) and the involvement
in a MAPK pathway resulting in proliferative stimuli
(Additional file 2: Figure S3) have been reported.
Caveolin-1 contribution to the survival of chronically
SIV-infected T cells is intriguing, but remains specula-
tive and needs confirmation, e.g. by experimental data
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cells engineered to express Cav-1. Supporting evidence
for a biological relevance of Cav-1 via gp41 binding has
been published recently [57-62]. These interactions
have been assumed to modulate the viral fusion process
or endocytosis. Macrophages do not undergo lysis upon
HIV-1 infection and, therefore, are a suspected virus
reservoir. Recently, a contribution of Cav-1 to the modula-
tion of bystander apoptosis in HIV-1-infected macrophages
has been suggested. Strikingly, in these experiments,
Cav-1 restricts virus production and cell death through
gp41 binding and inhibition of Env-mediated bystander-
apoptosis of non-infected cells [63]. HIV-Tat has been
noted as being responsible for the induction of Cav-1
expression, with p53 activation being a necessary step
within that pathway (see below, and ref. [64]). More-
over, Cav-1 reduces HIV-1 replication in infected macro-
phages by interfering with LTR transcription by repressing
NF-κB activity, presumably via the acetylation of NF-κB
[57,65]. Furthermore, Cav-1 restores the efflux of choles-
terol impaired by viral Nef, thereby interfering with virus
budding from rafts and virus infectivity [66,67]. Hence,
Cav-1 is developing as a central molecule, putatively en-
gaged in distinct mechanisms leading to the reduction of
infectivity, interference with virus replication and apop-
tosis in chronic SIV infection of T cells. Our results sug-
gest that Cav-1 contributes to the phenomena observed in
chronic SIV/HIV infection of T-lymphocytes, either by its
signalling or structural properties.
Identification of non-differentially expressed key regulators
E2F1/4, p53 and Myc, and deregulation of apoptosis, cell
cycle and proliferation sub-networks
In general, HIV/SIVinfection induces cell-cycle arrest in
the G2/M phase and apoptosis of infected CD4+ T cells
and adjacent bystander cells. Since chronically SIV-infected
C8166 survived the detrimental effects of the infection,
the gene expression of the apoptosis and proliferation
sub-networks was followed and assessed. Both supportive
and inhibitory factors were identified at the transcriptional
level (Figures 3, 4 and 5).
Furthermore, using the network strategy Inter-Chain-
Finder (ICF), we identified several non-differentially
expressed key regulators (p53, E2F1/4, Myc/Max) that
play central roles in cellular processes. The mRNA
levels of these key regulators were not significantly af-
fected in either SIV-infected cell line. Their involvement
in the regulation was inferred by tracing the interacting
network (Additional file 2: Figure S3 and Additional file 3:
Figure S4). Both the upstream and downstream alter-
ations jointly pointed out the change in activity of those
regulators. These findings currently are only indirect
evidence. Nevertheless, a recent compilation of data
generating a landscape of cellular protein interactionswith viruses supports the findings that p53, E2F1 and
c-Myc play important roles in the HIV viral replication
cycle [68]. In total, 6 out of the 13 predicted ‘hidden’
key regulators listed in Additional file 8: Table S3 were
among the landscape of proteins interacting with HIV
(Myc, E2F4, RBL2, E2F1, TP53, EGR1) [68,69]. These
candidates have in common that they can regulate cell
growth. Obviously, the findings underline the effective-
ness of the ICF strategy.
p53 (TP53) was predicted by ICF as a key regulator in
the chronically infected C8166 T cell line, because of the
signalling pathways affecting its activities and its ef-
fector/target transcriptional pattern (Additional file 2:
Figure S3 and Additional file 3: Figure S4). Eight out of
the 54 known PDs were affected (P-value = 2.11E-5) as
identified by the ICF (Additional file 8: Table S3). The
number of up- or downregulated target genes of p53
was equal (Additional file 3: Figure S4). The results
suggested that p53 was activated in the permanently
SIV-producing cell line. P53 might lead to the induc-
tion of Cav-1 expression, which has been reported for
HIV- infected macrophages.
Mainly, p53 functions in apoptosis induced by DNA
damage and in cell cycle regulation sustaining G1 and
G2 arrest. In general, apoptosis is triggered by external
signals via plasma membrane receptors (extrinsic FAS or
TNF-α receptor pathway) or within the cell via mito-
chondria and associated proteins (intrinsic pathway).
The initial trigger is transmitted to regulator caspases
and followed by executor caspases that finally interfere
with cell integrity. P53 activation results in the stimula-
tion of the intrinsic or extrinsic pathway of apoptosis,
processes that also can occur in chronically SIV infected
T cells because of the predicted p53 activation. Increased
Cav-1 levels contribute to apoptosis inhibition [63,64].
Further experiments are therefore necessary to confirm
the p53 status in chronically SIV-infected T cells and to
clarify its cellular and viral implications.
The expression of at least 26 genes (Additional file 4)
of the apoptosis pathway in mammals was deregulated
in the chronically SIV-infected T cell line. We found
pro-apoptotic proteins significantly upregulated, such as
lymphotoxin alpha (TNF superfamily, member 1) (LTA)
and its receptor TNFRSF1B (Figures 3 and 4).
The expression of TRAF-1, which is able to mediate
anti-apoptotic signals from TNF-receptors, appeared to
be repressed (data not shown). The expression of pro-
apoptotic genes, such as caspases 3 and 8, which has been
reported to be upregulated by viral Vpr and Tat-proteins,
respectively, was not affected.
The expression of pro-survival genes was also observed
[70]. Notably, the insulin pathway, which is involved in
proliferation, was activated (PTPRF, INSR, IGF2, Figure 4).
However, insulin-like growth factor binding protein 3
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Figure 7 Caveolin-1 expression is induced in chronically
infected C8166 T cells. A: Caveolin-1 mRNA expression is induced
in human T cell chronically infected by SIV. Products from LightCycler
PCR from mRNA isolated from infected and mock-infected T cells are
shown. Specific exon-spanning primers were used to amplify Cav-1 or
ribosomal protein 9 (RPS9) for normalization. Lanes 1, 2 acute infection;
lanes 3, 4 chronically SIV-infected T cells; lanes 5, 6 mock-infected cells;
lane 7, water control. The expected products of 318 bp (top Cav-1
lanes 3, 4) and 95 bp (bottom RPS9, lanes 1–6) were identified in 2%
agarose gels. B: Western blot detection of caveolin-1 in SIVmac251 H32
C8166-P cells. Equal amounts of cell lysates from human T cell C8166
(lane 2) and from human T cell C8166 chronically infected by SIV
(lane 3) were separated by SDS PAGE and Western blot was carried
out by using rabbit anti-caveolin-1 antibody as the primary antibody.
NIH 3T3 cell lysate (1/50 dilution) was used as the caveolin-1 positive
control sample (lane1). Arrow depicts caveolin-1; in lane 1, the two
isoforms of caveolin-1 found in NIH 3T3 cells are visible.
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lated in chronically SIV-infected T cells (Figure 4).
Induction of apoptosis of CD4+ T cell as a result of HIV/
SIV infection is complex and caused by several mechanisms
elicited by viral and cellular proteins [71,72]. Pro- as well as
anti-apoptotic signals were observed upon a chronic course
of SIV-infection. However, the net effect of these opposite
reactions results in an inhibition of apoptosis.
Furthermore, the ICF predicted a change in E2F1/E2F4
activity (Additional file 2: Figures S3 and Additional file 3:
Figure S4). Transcription factor E2F1 initiates proliferation
and apoptosis. Interestingly, the balance of cell proliferation
and apoptosis has recently been shown to be regulated by a
subset of E2F1 target genes that are specifically repressedby PI3K/Akt signalling [73]. Proliferation is initiated when
E2F has been activated through the phosphorylation of its
inhibitor Rb (Retinoblastoma protein) by cyclin D/ CDK4/6
kinase complex [74]. Whereas the genes directing
E2F-linked apoptosis were not affected, 8 out of 9 E2F1
targets linked to proliferation (CCNA2, BARD1, KIF11,
MSH2, PBK, GAS2L1, FNTB, NDC80) (Additional file 3:
Figure S4, Figure 5B) were downregulated in the per-
manently SIV-releasing cells compared with the control,
predicting alterations in cell growth. Of note, whereas
upstream IMCs were clearly affected, the P-value for
E2F1-affected target genes (also for RBL2 from control
samples) indicated a low significance (Additional file 8:
Table S3). However, the low significance needs to be
interpreted with caution because of the large number of re-
ported PD interactions from high-throughput measure-
ments, which might include a considerable number of false
positives. Anyway, the finding that eight out of the nine
E2F1 targets were involved in the proliferation process adds
high confidence to the importance of E2F1.
CCNA2 (Cyclin A2), FNTB (farnesyl transferase, CAAX
box, beta) and NDC80 (kinetochore complex component)
promote cell-cycle transitions, whereas the expression of
BARD1 (BRCA1 associated RING domain 1), MSH2 (mutS
homolog 2, colon cancer, nonpolyposis type 1 (E. coli)),
GAS2L1 (growth arrest-specific 2 like 1) is important for
cell cycle arrest. Although the eventual effect (promoting or
arresting) on cell cycle progression is a tug of war between
the two groups of these genes, the downregulation of these
genes probably counteracts SIV-induced cell cycle arrest,
which has been reported to occur in the G2/M phase and
is mediated by the viral Vpr protein [75].
In addition, several genes interacting with E2F1/E2F4
and regulating DNA damage repair (NBN, ATR) were in
the disturbed sub-network (Figure 4). ATR, NBN, and
CHEK1 are involved in the process of DNA damage-
induced checkpoint activation. Furthermore, five genes
of 42 genes for the cell cycle checkpoint were found in the
ATR (ataxia telangiectasia and Rad3 related) sub-network
(binomial distribution probability P-value = 1.27E-6), which
were affected in chronically infected C8166, namely ataxia
telangiectasia and Rad3 related (ATR), p53 (TP53), nibrin
(NBN), pro-myelocytic leukemia (PML) and CHK1 check-
point homolog (CHEK1) (Figure 4). Although CHEK1 and
PML did not show a significant mRNA change, other genes
interacting with them in the sub-network were significantly
affected in transcription (Figure 4). Those signal transduc-
tion or protein-protein interactions were, therefore, possibly
affected. Consequently, the related sub-network as a whole
might be influenced in executing its functions.
Notably, processes of DNA damage regulation are known
to accompany retroviral integration. For instance, PML
and integrase interactor 1 (INI1, hSNF5) associate with
the HIV-1 integrase-containing pre-integration complexes
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ATR, which activates checkpoint signalling upon genotoxic
stresses, was downregulated in permanently SIV-infected
T cells. ATR is also assumed to be required for appropriate
DNA integration of HIV-1 viral DNA [77]. Interestingly,
retroviral integration has recently been shown to induce
apoptosis by the activation of the DNA-dependent protein
kinase (DNA-PK). Downregulation of ATR followed by
interruption of the integration process of viral DNA,
therefore, might inhibit provirus formation and counteract
programmed cell death in chronically SIV-infected T cells.
The results suggest that E2F1 activities have been
repressed and consequently might contribute to cell
survival by preventing viral integration, virus-induced
apoptosis and growth arrest via some of its target genes.
Furthermore, the elongation of the G1 phase to increase
transcription from the retroviral LTR, a property suggested
for activated p53 and E2F in acute infection, should not
occur in chronically infected cells because of the assumed
activity pattern [68]. For E2F4, the number of downregu-
lated target genes was 15 in contrast to only 7 upregulated
target genes (Additional file 3: Figure S4), which indicates a
more inhibitory role of E2F4 in this context.
C-Myc downregulates or represses various cell adhesion
genes (αLβ2, α3β1 integrins), differentiation specific genes,
differentiation markers, cell cycle/growth arrest and DNA
damage genes (GADDs, p27KIPI). In most cases, an INR se-
quence (initiator negative regulation) is present in the pro-
moter of these genes. In contrast, genes upregulated by
Myc are integral to DNA synthesis and cell cycle regulation
and have canonical E-box elements and lack INR sites. Up-
regulation of these genes is accompanied by cellular trans-
formation. The presence or absence of INR elements in
myc-targeted genes suggests that Myc plays an eminent role
in the transition from proliferating undifferentiated cells to
quiescent fully differentiated cells [78]. C-myc activity was
affected in chronically SIV-infected T cells as predicted by
the ICF and might promote the survival of these cells.
Finally, EGR1 (early growth response protein 1) activity
was also predicted by the ICF to be affected (Additional
file 2: Figure S3 and Additional file 3: Figure S4). EGR1 is
a transcriptional regulator functioning in differentiation
and mitosis. HIV-Tat protein transactivates the EGR1
promoter and this interaction has been associated with
neuronal deficiency caused by HIV-1. Furthermore,
EGR1 expression is downregulated in the SIV infection
of the hippocampus [79,80].
Other affected pathways and comparisons to known host
factors in HIV replication
Deregulation of chromatin formation and epigenetic alterations
In order to obtain information on the activation/repression
of expression by chromatin formation and epigenetic
mechanisms, the expression patterns for factors involvedin such processes were investigated. Interestingly, the
expression of H2A genes (HIST3H2A, HIST2H2AA3),
members of the histone family that wrap and compact
DNA into chromatin, was upregulated in the C8166-P
cell line (Figure 5A). Moreover, PLU-1 expression (putative
chromatin-binding motif, also known as JARID1B), was up-
regulated in chronically infected cells (Figure 5A). PLU-1
represents a H3K4 histone demethylase that is involved in
transcriptional regulation. SATB1 (special AT-rich binding
protein 1) is a protein binding to DNA associated to the
nuclear scaffold/matrix. SATB1 RNA abundance was lower
in chronically SIV-infected T cells (data not shown). SATB1
serves as a docking site for several chromatin-remodelling
enzymes (e.g. PML at the MHC-I locus) and recruits co-
repressors or co-activators directly to promoters and en-
hancers. Similarly, ATF-2, which represents a transcription
factor and probably exerts its effects on chromatin compo-
nents, was affected (Additional file 8: Table S3). Taken to-
gether, chromatin formation and epigenetic regulation
seem to be affected during the chronic infection of T cells,
possibly leading to distinct alterations in gene expression.
Other affected sub-networks and caveats
In addition to the sub-networks discussed above, several
other pathways or sub-networks were deregulated upon
chronic SIV infection (Additional file 5: Figure S2).
However, their involvement in SIV infection cannot be
discussed in such detail as that above. In particular, we
noted that parts of the T-cell receptor signalling network
(CD3Z, the gene for the ζ subunit of the T-cell receptor)
and parts of metabolic network, e.g. glycosylation pathways,
were deregulated (Table 2). Interestingly, similar to CD3Z
in an HIV-resistant T cell clone [81], CD3Z expression was
upregulated in chronically SIV-infected T cells in our study.
Finally, SMAD1 was identified as a top downregulated hub
in C8166-P cells (Additional file 5: Figure S2, Figure 5B,
Additional file 7: Table S2). SMADs transduce and modu-
late signals in multiple pathways (e.g. TGF-β, BMP)
and influence cell growth, apoptosis, morphogenesis,
development and immune response.
To some extent, differences in expression of single
genes might arise from cell variability, since neither
the chronically SIV producing cells were clonal, nor
were the cells from the acute infection assay uniformly
infected. Unfortunately, this kind of complexity is a
general problem in the majority of whole transcrip-
tome analyses except for the most-updated single cell
RNA-Seq analyses. An alternative approach, isolation
of newly infected cells is difficult to achieve, stresses
the cells and gives rise to another unpredictable variable.
Therefore, the current approach represents a compromise
on technical feasibility and informative value. However,
we think that the unspecific noise did not influence results
achieved for the main pathways identified in our analysis.
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process and surviving, SIV-releasing cells were out-
grown. The heterogeneity is suspected to be quite low,
since in the long term, the culture is dominated by
cells with growth advantage.
Comparison to gene expression profiles from chronic and
acute HIV-1 infection of human T cell lines
As expected, we found that several signal transduction
pathways and functional gene clusters involved in acute
and chronic infection had been identified in previous
studies of HIV infection of T cell lines, such as apoptosis
control, cell cycle control or chromatin modulation.
Most prominently, the cell survival was accompanied by
the loss of CD4 expression in many cases. Olivares
et al. generated gene expression profiles of chronically
HIV-infected H9 cells using cDNA microarrays [82].
When we compared these profiles to that of chronic-
ally SIV-infected C8166, 21 genes overlapped, a majority
being involved to cell cycle control (7) and apoptosis
(4) (data not shown). More than 50% of the gene over-
laps were regulated in the same direction. Obviously,
similar mechanisms seem to accompany the chronic
infection with HIV-1 and SIV of human T cell lines.
The affected members of the respective pathways were
often not identical in the different, infected cell lines.
For example, CFLAR (CASP8 and FADD-like apop-
tosis regulator, FLIP), CTCF (a chromatin modulator)
and RBM34 (KIAA0117) previously identified in chronic
HIV-1 infection of T cell lines H9 (CFLAR) and SupT1
(CTCF, RBM34) were not affected in chronic SIV in-
fection of C8166 [81,82]. This suggests that interfer-
ence with a pathway is more important than regulation
of a specific gene member. Finally, specific genes and
gene families reported to be deregulated in the acute
HIV infection of CD4+ T CEM cell line, such as cer-
tain genes in cholesterol biosynthesis, were not influ-
enced in lytically or chronically SIVmac251-infected
C8166 T cells [83,84].
Deregulation of HIV-dependency factors (HDFs)
Host factors required for HIV replication have been iden-
tified recently by functional genomic screens [8,85-87].
Unfortunately, little overlap is seen between the results
of these studies; this is clearly attributable to differences
in experimental design and scope [88]. In their RNAi
screen, Yeung et al. have identified 252 human genes
whose chronic knockdown in Jurkat cells apparently in-
terrupts productive HIV-1 infection [87]. Interestingly,
their results are mostly distinct from the HeLa and
293 T candidates described by Brass et al. [8], Koenig
et al. [85], and Zhou et al. [86], possibly because a T cell
line better reflects the physiological condition of an HIV
infection than HeLa or 293 T cells.Notwithstanding the discrepancies, these studies have
prompted us to investigate whether any of these HDFs
was differentially expressed in the chronically or acutely
SIV-infected C8166. Out of the HDFs ranging in number
from 233–295 detected in four investigations, 18 HDFs
were differentially expressed in the permanently SIV-
releasing cell line compared with the control (Figure 8).
Three genes were found in the HDFs listed in Yeung
et al., 4 in Brass et al., 6 in Koenig and colleagues and
6 in Zhou et al. Not surprisingly, only one HDF (CD4)
was identified in two RNAi screens, and none was
present in all four screens. In addition, only 3 genes
were differentially regulated compared with the acutely
infected cell.
The HDFs found in the chronically SIV-infected T
cells function in HIV docking to the plasma membrane
(CD4, SIAT9), cell cycle control (BLK, PTPRN2), apoptosis
(BLK, TNFRSF1B), HIV RNA export (XPO1, SAM68) and
immune signalling (CD4, IL1A). Four of them are tran-
scriptional regulators (MRF, NCOR2, NCOA3, PLU-1).
AP1G2, an adaptin, is part of the adaptor complex involved
in clathrin-coated vesicle transport, whereas LAPTM5
and NDUFA10 reside in specific compartments (lysosomes,
mitochondria).
Noteworthy, the caveolin contribution to HIV infec-
tion has also been observed in two functional genomic
screens by Brass et al. and Zhou et al. The authors re-
cently identified Cav-2, a Cav-1 relative that needs Cav-1
for transport and function, as one of hundreds of HDFs
that are likely to play a relevant role in HIV pathogenesis
in acute infection of HeLa-derived cell lines [8,86,89].
However, Cav-2 is not found in RNAi screens of infected
293 T or human lymphocytes.
Furthermore, 21 Diff genes of chronically SIV-infected
T cells were identified in the VirusMINT database, a
compilation of virus-interacting human proteins pub-
lished in 2009 (data not shown) [69]. Among the sub-
group of proteins interacting with HIV, we found Cav-1,
CD4, CD9 and the complement receptor CR2, two histone
genes, eight HLA genes (all major histocompatibility com-
plex, class II), two RNA export factors (SAM68, XPO1),
and the HIV Rev-binding protein HRB. Moreover,
PLAU (plasminogen activator, urokinase type), PDIA5
(a protein disulfide isomerase) and ACTA2 (an α-actin)
were also found.
Nucleoporins are part of the nuclear pore complex,
which regulates the nucleo- cytoplasmic transport of
molecules. Several nucleoporins (Nup 107, 133, 153,155,
160, 185) have been identified as HDFs (listed in [8])
and some of them are required for the uncoating and in-
ward trafficking of the pre-integration complex. Notably,
Nup205, a nucleoporin required for the long-term main-
tenance of the nuclear pore complex, was downregulated
in chronically SIV-infected T cells (Figure 5A). NUP205
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ically HIV-1 infected H9 T cell line [82] and has been
noted as an HIV interaction partner in a proteomic
screen involving affinity purification and mass spectrom-
etry [90], but has not been identified in the 4 HDF
screens through RNAi mentioned above. Apparently,
NUP205 escaped the RNAi approaches; this might be
because these screens covered only gene products that
are not essential for cell survival. Thus, Nup205 might
represent a novel factor, the downregulation of which is
involved especially in establishing cellular resistance to
SIV-replication in T cells.
Conclusion
A conventional pathway analysis method and a new
network-and-knowledge-based strategy were used in
gene profiling experiments to identify potential key
genes and sub-networks associated with cell survival in
a chronic SIV-infection. Our results demonstrate that
several complex sub-networks together, rather than a
single pathway, play a role in the survival of the chron-
ically SIV-infected human CD4+ T cell line. We have
not only confirmed certain previously reported path-
ways, but also revealed several new sub-networks that
might jointly contribute to the persistence mechanism
of SIV infection of T cells.
In particular, by tracing the interaction networks,
putative ‘hidden’ key regulators were identified in
chronically infected T cells; such regulators were not
significantly affected at the mRNA levels. We also iden-
tified differentially-expressed top hubs, e.g. caveolin-1,
through the network analysis. Further experimental
studies confirmed caveolin-1 upregulation and CD4
downregulation in the survival network of chronically
SIV-infected human CD4 T cells. At a network level, the
analyses revealed that chronically SIV-infected T cells
releasing infectious virus particles counteracted various
cellular processes that have been described to partici-
pate in the early phase of viral replication and cell death
in acute infections. Re-infection of the chronically in-
fected cell is probably prevented by reduced CD4 recep-
tor availability, interference with alternate routes of
viral entry, nuclear transport, integration of proviral
DNA, RNA export and cell survival afforded by repro-
graming of apoptosis and cell growth. Late processes
leading to the generation of new virus do not seem to
be influenced to such an extent. This suggests that the
high virus productivity of the chronically infected T cell
line might be attributed to proviral transcription rather
than to ongoing viral replication. The investigation
raises several hypotheses and possible sub-networks/
pathways that might contribute to cell survival of SIV
infection but these await further experimental confirm-
ation. With the help of the results from this study, single orcombined gene expression/depletion and other functional
experiments can now be designed to investigate further
their impact on infection by SIV and HIV.
Materials and methods
Cell culture and virus assays
C8166 cells were grown in RPMI 1640 medium sup-
plemented by 10% fetal bovine serum and antibiotics
(R-10 medium). C8166 permanently SIVmac251/32H
releasing cell line was kindly provided by Christiane
Stahl-Hennig who also established this cell line, which
produces a high titre of infectious SIV without any evi-
dence of lytic destruction [91]. The cell line is not clonal,
but heterogeneity is expected to be low, since in the long-
term, the culture is dominated by cells exhibiting a growth
advantage. For virus titration, 30,000 C8166 cells were
seeded into each well of a 96-well plate in 50 μl medium.
A tenfold serially diluted virus stock (100 μl) was added to
each well in 8 replicates. After 4 days, 50 μl fresh medium
was added. After 7 days, cells producing virus proteins
were stained by an indirect immunoperoxidase assay
[92,93]. The number of infectious viruses (TCID50) was
scored by using the Reed and Muench method [94].
For quantification of viral RNA copies from the cell
supernatant, RNA was extracted following the MagAttract
Viral RNA M48 Kit virus mini protocol (Qiagen, Germany).
RT-PCR was carried out as described by using the ABI
7500 Real Time PCR System [95].
Quantification of the proviral load was carried out by
using the same primers and PCR conditions as for RNA
quantification, except that the RNA was substituted by
50 and 100 ng of genomic DNA, isolated at four time
points over a period of five months, and the RNA stand-
ard was replaced by a DNA-based standard. For the de-
termination of proviral copy number, we assumed that
the amount of DNA per cell equalled to 6.6 pg.
To estimate the number of SIV-particles released per
cell per 24 h, the C8166 cells were washed 5 times and
finally cultured for 24 h at a density of 106 cells per ml
R-10 medium. RNA copy numbers were determined
from the wash solutions and after 24 h. For a conserva-
tive estimate, the RNA copy numbers detected in the
final wash solution were subtracted from the RNA
copy numbers obtained after the 24 h culture. Finally,
the RNA copy numbers were divided by two to calcu-
late number of viral particles. The results represent the
mean from three independent experiments.
Halo-FISH was performed as described in Goetze
et al. by using the SIV GagEnv fragment of plasmid
pGX10-SIV-GE [96].
Infection and RNA isolation
For each microarray experiment, 3×107 cells were harvested
by centrifugation (10 min, 600×g). To minimize potential
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2008
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Yeung
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Gene
symbol full name
AP1G2
Adaptor related protein complex
1, gamma 2 subunit Vesicular transport
BACE2 Beta-secretase 2
Cleavage of amyloid
precursor protein
BLK B-lymphoid tyrosine kinase
B-cell development, growth
arrest and apoptosis,
insulin signaling
CA2 Carbonic anhydrase II
Catalyzes reversible
hydration of carbon dioxide
CD4 T cell surface glycoprotein CD4
HIV attachment, immune
signaling
C11ORF9
Chromosome 11 open reading
frame 9, myelin gene regulatory
factor Transcription regulator
IL1A Interleukin-1 alpha
Immune response,
inflammation
JARID1B
Jumonji, AT rich interactive
domain 1 B (RBP-like), PLU-1
Transcription, H3K4 histon
demethylase
KHDRBS1
Sam68, Src-associated
substrate in mitosis of 68 kDa
HIV RNA export and
translation
LAPTM5
Lysosomal protein
transmembrane 5 Lysosomal protein
MANBA Beta-mannosidase
Metabolism, glycosylation,
glycosyl hydrosylase
NCOA3 Nuclear receptor coactivator 3 Transcriptional co-regulator
NCOR2 Nuclear receptor corepressor 2 Transcriptional co-regulator
NDUFA10
NADH dehydrogenase
(Ubiquinone) 1 Alpha
Subcomplex, 10
Electron transfer in
mitochondria
PTPRN2
Protein tyrosine phosphatase
receptor pi
Cellular signaling, cell
growth and differentiation
ST3GAL5 Sialyltransferase 9 (SIAT9)
HIV attachment, GM3
Synthetase
TNFRSF1
B
Tumor necrosis factor receptor
superfamily, member 1 B Apoptosis
XPO1
Exportin 1 (CRM1 Homolog,
yeast) RNA export
Differentially expressed gene in acute SIV
infection
ARHGEF12
Rho guanine nucleotide
exchange factor 12
Cell signaling, G protein
coupled receptor-
dependent, Rho GTPase-
dependent
OR2W1 Olfactory receptor 2W1
Cell signaling, G protein
coupled receptor-dependent
RNF170 Ring finger protein 170 E3 ubiquitin-protein ligase
Figure 8 Occurrence of differentially expressed genes from SIV-infected T-cells in RNAi screens for host factors required for HIV
replication. Differentially expressed (Diff) genes of acute and chronic SIV infection of T cells were identified in four published RNAi screens for
HIV dependency factors. Diff presence is indicated by a filled circle. Additional symbols as in Figure 5.
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permanently SIV-producing C8166 were re-suspended
using 20 ml old and 10 ml fresh R-10 medium, and in-
cubated for 24 h at 37°C in a 5% CO2 humidified cham-
ber. For the acute infection, 3×107 un-infected C8166
cells were harvested and re-suspended in 20 ml stock
solution of SIVmac251 (multiplicity of infection: 0.2)
grown on C8166 cells in R-10 medium and 10 ml freshR-10 medium. Cells were incubated for 24 h at 37°C in a
5% CO2 humidified chamber. After 24 h, cells were har-
vested and processed for immediate RNA isolation. The
number of viral particles present in the virus stock solu-
tion was determined by real-time PCR. Comparing the
results of the real-time PCR with those obtained by
virus titration revealed a ratio of non-infectious: infec-
tious viral particles of about 4000:1. Each cell was thus
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which reflect the number of virus particles present in
the supernatant (i.e. “old” medium) of the permanently
SIV-producing cell line.
Total RNA was isolated by using PeqGold TriFast FL
RNA isolation kit (PeqLab) and quality was checked by
formaldehyde gel electrophoresis. Prior to microarray
analysis, a second RNA quality check was performed by
an Agilent Bioanalyzer.
Microarray analysis
The RNA was labelled and hybridized to Affymetrix mi-
croarrays. All the microarrays included in this work met
broadly accepted quality control standards, including
present call percentage (40-49%, an ideal spread <10%),
GAPDH 3’/5’ or 3’/M ratios (0.77-1.0, ideally to be <4)
and normalized unscaled standard errors (NUSE) median
(all <1.02, ideally to be < 1.1). According to the Affymetrix
recommendation, background levels should be less than
100 (our arrays spread from 63 to 89). Furthermore, in this
study, BioB controls received present calls for all the 6 sam-
ples, indicating good detection levels of even low abundance
mRNA and low noise. The intensity levels for BioB, BioC,
BioD and Bio-cre showed increasing expression in all the ar-
rays as expected, indicating a good hybridization process.
The expression ratios for each mRNA transcript on
Affymetrix HG U133A genechips (25 mer oligonucleotide
probe sets) between samples and controls were determined
by the software Microarray Suite 5.0 (Robert Geffers, HZI).
First, all the transcriptional probe sets (322) were excluded
corresponding to more than one gene according to the
annotation of Affymetrix chip probe sets from Affymetrix
website. In this work, we performed two independent
experiments. To assure safer and more reliable results, we
only filtered for the transcriptional probe sets with the same
detection call (according to one-sided Wilcoxon Signed-
Rank test, p < =0.05 is present, p > =0.065 is absent and
between them is marginal) in the two repetitions. The
detection call was also assigned as being marginal, if the
detection call of one probe was absent or present in one
experiment but was marginal in the other experiment. Sub-
sequently, both absent genes (AA) in the given sample and
control were excluded. If a transcript was detected with
more than one probe, the expression change of the probe
with highest response was regarded as the expression
change of the given gene. Changes in expression levels
equal to or greater than two-fold (corresponding to 1
or −1 after log2 transformation) after SIV infection
were regarded as significantly differentially expressed.
Otherwise, they were considered as NDiff genes.
Integrated molecular networks of human cells
The conventional methods are restricted to identifying
candidate genes that are differentially expressed underconditional or pathogenic changes. However, many
key regulators exert their effects mainly through post-
transcriptional and/or post-translational modifications.
Thus, they are not recorded by standard DNA-microarray
analysis. To address this issue, we developed a new ap-
proach, termed Inter-Chain-Finder (ICF), that can be used
(1) to find potential interactive molecular chains (IMCs)
affecting the activities of NDiff regulators, (2) to identify
the ‘hidden’ key regulators and (3) to uncover the inte-
grated responsive network. The ICF is based on an inte-
grated large-scale molecular network and the tracing of
responsive pathways/network and IMCs.
To establish an integrated molecular network for human
cells, we here uniformed all the related interaction data
from the databases such as KEGG (www.genome.jp/kegg/),
BIND (www.bindingdb.org) and HPRD (www.hprd.org).
For the BIND database, all the interactions between hu-
man and other organisms were removed. We also ex-
cluded the interactions between genes (proteins) and
small molecules (e.g. metabolites). Although these in-
teractions might have been useful regarding feedback
regulation, they were not included, as this work was
mainly based on microarray data. Furthermore, the in-
teractions between genes (proteins) and protein com-
plexes were not taken into account. In the BIND
database many interactions were removed because
genes were deleted or discontinued according to the
NCBI GenBank database. Some interactions with genes
(proteins) also had gene information ID (GI) but with-
out matched Entrez GeneID. These interactions were
also excluded. Some proteins were not assigned GeneID
by BIND, although they had ID according to GenBank. We
systematically checked them and assigned them corre-
sponding GeneIDs. These interactions were divided into
two categories: protein-protein interactions (PPIs) and
protein-DNA interactions (PDs), namely potential gene
regulatory interactions.
From the KEGG database, 39113 interactions were
obtained. Among them, 23291 were enzyme-enzyme re-
lationships (EERs), meaning that two enzymes catalyze
successive reactions. Theses interactions form the meta-
bolic network in which nodes represent enzymes. The
representation of a metabolic network is similar to the
reaction network representation [97]. Together, 15822
interactions were PPIs or PDs. Since the KEGG data are
based on pathway information, all the interactions are
assigned a pathway index, whereas the interactions from
BIND and HPRD do not have this attribute. These indexes
have been used for affected pathways/sub-networks calcu-
lation and identification. In addition, all the PPIs from
KEGG have more detailed information about the directed
relationships such as activation, inhibition, phosphoryl-
ation or ubiquitination etc. and PDs have specific rela-
tionships, e.g. expression or repression. IMCs can be
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entire regulatory network (12146 interactions) is directed
from one regulator to one targeted gene.
Subsequently, the interactions from BIND, HPRD and
KEGG were compared to exclude repetitions. Because
EERs uniquely exist in KEGG, they were not included in
the comparison. Although a large number of additional
PPIs from BIND and HPRD were added, all these extra
PPIs were undirected. Most of the PPIs from KEGG
had the direction, except for those with association or
dissociation relationships. To obtain more complete
information on interactions, peer-reviewed literature
was mined and some additional interactions, especially
for the mainly studied gene Cav-1, were added manually
in this study. Finally, 86516 interactions with 11976 genes
were obtained that included PPI, PD and EER.
For further analysis, the integrated network consisting
of PD, PPI and EER interactions was correspondingly
divided into three parts: transcription regulatory net-
work, signal transduction network (including protein-
protein interactions) and metabolic network. Since the
three parts interact with each other, the method can
comprehensively analyse the mutual effects among
them, e.g. the way that the PD network controls the
PPI or EER network or the manner in which the PPI
network controls the PD network.
Present and affected signal transduction sub-network
If both genes of a given signal interaction pair are present
in the sample according to detection call of Microarray
Suite 5.0, this interaction is present. Because it is difficult
to determine which expression level can function in signal
transduction, we also consider the signal interactions with
marginally expressed genes as being ‘present’. If at least
one gene of a present signal interaction is differentially
expressed, we term it as a significantly affected interaction.
The significantly affected interactions constitute the sig-
nificantly affected signal transduction network. The defini-
tions concerning the signal network in the sample are also
applied to the control.
Significantly affected regulatory sub-network
If both the regulator and the targeted gene are signifi-
cantly differentially expressed, the PD is apparently sig-
nificantly affected. If the targeted gene is differentially
expressed but the regulator is not, the interaction is also
potentially significantly affected since the activities of
transcriptional factors are often modulated via posttran-
scriptional or posttranslational modification or ligand
binding. Although the signal transduction network is far
from being complete, we assume, in this work, that a
regulator is not significantly affected if no corresponding
significantly affected signal transduction chain can be
found for the regulator. Since mRNA expression of someregulators was either present/marginal in the infected
but not in the control samples, or vice versa, the signifi-
cantly affected signal transduction chains were traced
separately in control and treated samples.
Significantly affected metabolic sub-network
If both genes in one EER are differentially expressed, this
interaction is termed as a significantly affected metabolic
interaction. A significantly affected metabolic interaction
is defined in the conservative way stated above, which
simplifies the complex theory of metabolic control. The
significantly affected metabolic network is made up of
significantly affected EERs.
Principle of the tracing algorithm for possibly affected
interactive molecular chains
The tracing algorithm searches for the upstream effectors
that might modulate the activity of the given regulator
and minimizes uncertainties arising from undirected
protein-protein interactions (e.g., from BIND).
In the first step, all PPIs are identified that are
linked to a given non-differentially-expressed regula-
tor. These PPIs represent the first level (Figure 2B) of
possible, significantly affected IMCs, which might
modulate the activity of the given regulator. Directed
PPIs (e.g. with activation or inhibition relationship) with
significantly differentially expressed gene(s) are considered
to most likely affect the activity of the given regulator.
For undirected PPIs (e.g. from BIND or HPRD), the
differentially-expressed gene products can bind to the
given regulator and hence also possibly affect the regu-
latory activity of the given regulator but with some un-
certainties regarding the direction. In the following
paragraph, an approach is proposed to compensate for
these uncertainties.
This tracing algorithm is aimed at finding the most
direct (shortest), significantly affected IMCs that might
modulate the activity of the given regulator. Two types
of cases exist: IMCs with or without undirected PPIs.
If all the PPIs in the first level linking the non-
differentially-expressed regulator and differentially-
expressed genes are directed, the search is not switched to
the next level and the resulting IMCs are composed of
only those directed PPIs with the chain length of one.
On the other hand, if some PPIs that link the non-
differentially-expressed regulator and differentially-
expressed genes are undirected, we extend the interaction
chains for directed/undirected PPIs that link the non-
differentially-expressed regulator and non-differentially-
expressed genes (“ND-PPIs”) from the first level by
searching for directed PPIs in the second level (Figure 2B)
which connect differentially-expressed genes and non-
differentially-expressed genes from ND-PPIs of the first
level. For convenience, we call PPIs linking differentially-
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“Diff-PPIs”. From the second level or higher levels, we only
search for directed PPIs. Thereafter, we perform the core
steps: if any directed Diff-PPI from the second level is
linked to a ND-PPI, the search is not switched to the next
level. The search is continued for the given ND-PPI to
identify all the other directed Diff-PPIs in the second level,
which link to that ND-PPI. This iteration process is per-
formed for each identified ND-PPI from the first level.
The resulting IMCs have the chain length of two.
If only directed ND-PPIs but no directed Diff-PPIs
from the second level are found for any ND-PPI from
the first level, we switch to the next higher level until
any directed Diff-PPI linking to any ND-PPI is found in
the current level, where we would repeat the core steps
as described above. The chain length of the resulting di-
rected IMCs is in the order of the current level in which
we have found the Diff-PPIs (see Figure 2B and as exam-
pled in Additional file 2: Figure S3). All the potential,
significantly affected IMCs for the given regulator can be
found by the above algorithm.
Statistical analysis
Assessment of the statistical significance of affected
regulators and sub-networks
We further calculated whether the number of PDs affected
by a given regulator (or the number of affected PPIs and
EERs) was obtained by chance or not, as only being affected
by the IMCs is not sufficient to judge the significance of the
given regulator. The binomial distribution was used to cal-
culate the P-value, e.g., the chance that mex PDs were found
to be regulated by the given regulator in the affected net-
work extracted from all the available regulatory network
was calculated by the formula:
p ¼
Xnex
i¼mex
nex!
i! nex−ið Þ! 
m
n
 i
 1−m
n
 nex−i ð1Þ
Where: n, number of PDs in all the available regula-
tory network; m, number of all the known PDs regulated
by the given regulator; nex, number of PDs existing in
the affected regulatory network; mex, number of PDs in
this extracted network regulated by the given regulator.
If the significance for the given regulator is high, the
number of PD found to be regulated by this regulator is
not obtained by chance.
Analogously, we assessed the number of affected PPIs
or EERs that belong to given signalling transduction or
metabolic sub-networks expected under the null hypoth-
esis. The significance that mex EERs were found to be-
long to the given sub-network in the affected metabolic
network could also be calculated by Equation 1. Simi-
larly, the significance for the affected signaling transduc-
tion sub-networks according to KEGG was obtained byEquation 1. The sub-networks in the highest ranking po-
sitions ordered by significance values were the most pos-
sibly affected sub-networks.
Calculation of the enrichment of genes in human GO processes
A module of the ICF that is not included in the GO-viewer
software calculates the enrichment of genes in the human
GO processes and, thus, investigates the detailed functions
for the protein-protein network and regulatory network.
For each human GO biological process, the probability that
the observed number of genes could be found by chance
was determined by calculating the cumulative binomial dis-
tribution probability. In this work, the calculation of prob-
ability is different from that in most of other GO terms
searching programs, e.g. GeneMerge [98]. We calculate the
probability of processes in the given degrees of the GO
hierarchical tree instead of all the GO terms in the whole
tree. Suppose that there are n annotated genes in the given
GO process of the hierarchical tree (in this work, the de-
gree from four to nine is considered). Among them, m
genes are assigned to a given GO process term. nex genes
exist in the test sample. In this test sample, mex genes are
known to be involved in the given GO process. The signifi-
cance can also be calculated by Equation 1.
Lysis of cells, SDS-PAGE and Western blot analysis
Cells were treated with lysis buffer (10 mM Tris pH7.5,
50 mM NaCl, 1% Triton X100, 60 mM octylglucoside
(Roche), 1 mM aprotinin, 1 mM leupeptin, 1 mM PMSF)
at 4°C for 30 min followed by centrifugation in an
Eppendorf centrifuge at 15000 rpm. Cleared supernatants
were processed further or stored at −20°C. SDS-PAGE
and Western Blot analysis for caveolin-1 detection were
performed as described previously [52].
Real-time RT-PCR
RT-PCR was performed from equal amounts of total
RNA (640 ng) by using LighCycler™ technology and a
RT-PCR amplification kit (Roche Diagnostics). Caveolin-
1 specific signals were obtained by intron-spanning RT-
PCR (forward primer hCav1_54 GAA AGA GAG AAT
GGC GAA GTA; reverse primer hCAV1_371 CGG
GAA CAG GGC AAC ATC TAC, PCR product mRNA
calculated length 318 bp). Values were normalized by
using probes for RT PCR of the house keeping gene for
ribosomal protein S9 (RPS9) kindly provided by Dr.
Wiebke Hansen (forward primer 5′- CGC AGG CGC
AGA CGG TGG AAG C, reverse primer CGA AGG
GTC TCC GCG GGG TCA CAT). For confirmation of
product identity, the amplification products were sepa-
rated by 2% agarose gel electrophoresis.
Expression levels of other transcripts were determined
using the ABI Prism 7500 Real Time PCR System. 1 μg
of total RNA was additionally purified with gDNA
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verse transcribed by using the QuantiTect reverse tran-
scription kit (Qiagen, Germany). Four serial dilutions of the
cDNA were amplified in duplicate by using commercially
available primers (Gene globe, Qiagen, Germany) and the
ImmoMix polymerase kit (Bioline, Germany) supple-
mented with Rox and Sybr Green. As standard, serially
diluted cDNA from HumanXpress Ref universal refer-
ence total RNA (Superarray Bioscience Corporation)
was employed. The reciprocal dilution factor of the
standard was set arbitrarily as “copy number”. As fur-
ther controls, RPS9 expression was measured in each
sample. The relative “copy numbers” were compared
with those of uninfected C8166 cells and represent the
mean of all measurements. The results represent the
mean of two independent experiments.
Flow cytometry
Surface expression of CD4 was determined by flow cytome-
try. Uninfected and chronically infected C-8166 cells were
incubated for 30 min at 4°C in the dark with an antibody
directed against CD4 coupled to PE (clone M-T477, BD
Biosciences) at pretitrated concentrations in phosphate-
buffered saline (PBS) with 1% bovine serum albumin and
5% heat-inactivated normal mouse serum to block unspe-
cific binding. Subsequently, cells were washed, pelleted by
centrifugation and resuspended in 3% formaldehyde for fix-
ation. Samples were measured on an LSRII flow cytometer
(BD Biosciences) and data were analysed by using FlowJo
software (Tree Star, Ashland, OR).
Availability of supporting data and programs
The complete microarray dataset is available in the Gene
Expression Omnibus (GSE51594). The integrated database
and the ICF program are available in the webpage http://
www.uni.lu/lcsb/publications/integrative_network_analyzer.
Additional files
Additional file 1: Figure S1. Virus produced by C8166-P cells
(chronically SIV-infected cells) replicates similarly compared to highly
pathogenic SIVmac strains and causes a lytic infection. Description: In
vitro viral replication pattern of different SIV virus strains: (a) viral RNA
copies in cell culture supernatant of in vitro infected C8166 cells, (b) viral
RNA copies in cell culture supernatant of in vitro infected rhesus monkey
peripheral blood mononuclear cells (PBMCs). Before infection, C8166 cells
and rhesus PBMCs were washed. 2x106 cells were re-suspended in 2 ml
cell culture medium containing 50,000 TCID50 of SIVmac251/32H
(supernatant of C8166-P), or 60,000 TCID50 SIVmac239 grown on C8166
cells or 30,000 TCID50 SIVmac251 grown on rhesus monkey lymphocytes.
After an incubation step for 2 h at room temperature, cells were washed
twice and cultured in 1 ml RPMI 1640 medium (PAN Biotech, Aidenbach,
Germany) supplemented with 10% fetal calf serum (PAN Biotech, Aidenbach,
Germany), 100 U/ml penicillin (PAN Biotech, Aidenbach, Germany) and
100 μg/ml streptomycin (PAN Biotech, Aidenbach, Germany; complete RPMI
1640). Before infection, frozen rhesus monkey PBMCs were thawed and
stimulated with 2.5 μg ConA/ml overnight. Infection with different SIV strains
was performed as described above. After infection, monkey PBMCs werecultured in RPMI 1640 complete medium supplemented with 100 U/ml
recombinant human IL-2 (PeproTech, Hamburg, Germany). Viral RNA
copies in cell culture supernatant were determined at day 3 and 6 post
infection as described in Materials and Methods. Syncytia as evidence of
lytic infection are observed after infection of C8166 cells (c) and PBMCs
(d) with supernatant of C8166-P.
Additional file 2: Figure S3. Significantly affected interactive molecular
chains (IMCs) from chronically SIV-infected samples, which might
modulate the activity of the ‘hidden’ key regulators. Different ‘hidden’ key
regulators exhibiting no change in their RNA level are inferred by tracing
the upstream interactive molecular network. Regulators are represented
by diamonds. The black delta represents activation; the black circle
represents inhibition; a simple line without a symbol represents an
undirected relationship PPI of the two proteins. Red indicates significantly
increased, green, significantly decreased.
Additional file 3: Figure S4. Parts of putative, non-differentially
expressed key regulators and the affected transcription regulatory
network identified by the ICF. The figure shows genes that are regulated
at the RNA level in the chronically SIV- infected T cell line by non-differentially
expressed (NDiff), putative key regulators. The direction of the arrow is from
the regulator to the target gene. The target genes of E2F1 are indicated by
hexagons. For a detailed discussion of the effects of P53, Myc, E2F and p53 on
target genes and the cell, see text. The activity of transcription factor CREB is
accompanied by the upregulation of members of the MHC class II family
(HLA-D) and the downregulation of cyclin A 2 (CCNA2), a protein that
activates certain kinases to promote cell cycle transitions.
Additional file 4: Changes in gene expression in chronically and
acutely SIV- infected C8166 T cells. The file lists up- and downregulated
genes in chronically and acutely SIV-infected C8166 cells and the degree of
regulation (changes in gene expression, log2 transformed from fold
changes, versus mock-infected control cells).
Additional file 5: Figure S2. Protein-protein network of CD4+ T cells
significantly perturbed only in the chronically SIV-infected cells identified
by the ICF. Affected sub-networks in chronically infected C8166 cells are
shown. Red colour, significantly increased; green, significantly decreased;
white, non-differentially expressed (NDiff).
Additional file 6: Table S1. Top upregulated hubs in the chronic SIV
infection of C8166 T cells predicted by the ICF.
Additional file 7: Table S2. Top downregulated hubs in the chronic
SIV infection of C8166 T cells predicted by the ICF.
Additional file 8: Table S3. Top ‘hidden’ key regulators in chronically
SIV-infected C8166 T cells predicted by the ICF.
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